ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.
Goldvaser H, Yerushalmi R, Mutai R, Kuchuk I, Toker M, Paluch-Shimon S, Drumea K, Evron E, Sonnenblick A, Gal-Yam E, Sela GB, Shai A, Merose R, Bareket-Samish A, Soussan-Gutman L, Stemmer SM.
Goldvaser H, et al. Among authors: toker m.
Breast Cancer Res Treat. 2024 Nov 19. doi: 10.1007/s10549-024-07549-7. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 39560822